biote (BTMD) Stock Analysis & Winston Score
biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biote-branded dietary supplements; and sterile pellet insertion kits for men and women. The company was founded in 2011 and is headquartered in Irvine, Texas
Winston Score: 43/100 — Average
Mixed quality — meaningful strengths and weaknesses.
- Quality: Mixed (14/30)
- Growth: Weak (2/20)
- Cash Flow: Exceptional (9/10)
- Stability: Mixed (3/10)
- Valuation: Good (6/10)
- Ownership: Ownership data not available (not counted) (0/15)


